Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Pharma 5.0
Company News
Events
Directory
Search
Close search
Home
Company
Domainex
Domainex
Activities:
Research & Development
X
LinkedIn
Trending Articles
Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222
Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
Graphs and graph data science in drug discovery
Life sciences data expert Dr Alexander Jarasch discusses what work being done at the Institut de Recherches Servier can teach us about using modern data technologies for early...
Why smaller CDMOs should enhance their operational efficiency now: a CPHI expert guide
CPHI experts advise smaller CDMO's to invest in supply chain resilience, friend shoring and AI to keep up with the predicted uptick in funding for 2025
CPI collaborates with industry leaders to expedite drug manufacturing via digitisation
Digitising manufacturing technologies could allow enhanced ability to scale production, reduce costs and expedite the process
Janssen to adopt Johnson & Johnson brand as the company celebrates 100 years of UK operation
The company's pharmaceutical and medical technology segments will combine under the Johnson & Johnson brand name in the UK
Upcoming event
ASGCT Annual Meeting 2024
7-11 May, 2024 | Meeting | Portland, OR
See all
Related Content
Design & Build
New biology centre opened by HM Lord-Lieutenant of Cambridgeshire
The new three-storey facility provides over 24,000 sqft for Domainex’s expanding biology/bioanalytical departments
Drug Delivery
Amphista Therapeutics partners with Domainex drug discovery portfolio
Domainex has experience in the field of TPD with expertise in designing, synthesising, and profiling targeted heterobifunctional protein degraders
Finance
Domainex acquires more than £1m of Waters equipment
The SQ detectors will enable Domainex to increase its capacity to analyse and purify compounds with higher molecular masses
Research & Development
Domainex opens dedicated facility at Unity Campus
“The investment into our new facility has allowed us to create a fully dedicated suite of labs to conduct our biology services”
Drug Delivery
Parkinson’s UK and Domainex collaborate on inflammation therapy
The organisations plan to develop therapies targeting neuroinflammation to slow the progression of Parkinson’s
Research & Development
Queen’s University Belfast enters FLIP inhibitor collaboration
The university will work with Ipsen on the inhibitors, which have been supported by Domainex
Research & Development
Expanding the medicinal chemist’s toolbox
Ray Boffey, Executive Director of Medicines Research at Domainex, explains the applications and benefits of fragment-based drug discovery, fragment hit expansion and the use of flow chemistry
Subscribe now